News

Scientists exploit gene therapy to shrink tumors in mice with an aggressive form of breast cancer.

MOR202 exhibits encouraging clinical activity and good safety profile with best-in-class infusion tolerability.

Study builds on successful 350 patient Bladder Cancer trial.

The fight against superbugs has been bolstered thanks to a promising new therapy discovered by University of Adelaide researchers.

A new report gives the first ever picture of global investment in Ebola research and development (R&D), reporting that this investment might have come at the expense of efforts to develop drugs, vaccines and diagnostics for other neglected diseases, which collectively cause more than six million deaths every year in developing countries.

Scientists at The Scripps Research Institute (TSRI) have found evidence that a mutant protein responsible for most cases of cystic fibrosis is so busy “talking” to the wrong cellular neighbors that it cannot function normally and is prematurely degraded.

In a new study researchers from the University of Pennsylvania describe two related genes in the Musashi family that are required for colon cancer to develop, and that may be useful targets for effective treatment.

Combined company aims to be a leader in the field of tissue repair and regeneration.

Agreement for European manufacturing of its cell therapy products.

Rondo-Pak will offer a comprehensive portfolio of packaging and printed components.